ResearchOpen Access28 Jan 2025Scientific Reports Volume: 15, P: 3539 UtilizingTP53hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer Yen-Han Tseng Trieu Thi My Tran Chi-Ying F. Huang
Analysis: New research in lung cancerROBERT SIEGEL
Find all the latest on lung cancer at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
Get the latest lung cancer research and breakthroughs in lung cancer treatment, including maintenance therapies, advanced detection methods, and more.
ResearchOpen Access02 Jan 2025 npj Precision Oncology Volume: 9, P: 1 Breathing new insights into the role of mutant p53 in lung cancer Tianwei Chen Lauren M. Ashwood Kate D. Sutherland ReviewsOpen Access20 Nov 2024 Oncogene Volume: 44, P: 115-129 Delta-like ligand 3 (DLL3) land...
"Cancer is not one thing, it's actually hundreds of distinct diseases." This common refrain helps explain the frustrating experience oncologists have in testing a promising new drug only to find that it works well in some patients but fails for the majority. Such experiences have led researcher...
Most people with lung cancer are unaware of the benefits of regular exercise, yet new data show it can significantly reduce fatigue and improve well being. Results of two studies to be presented at the ESMO 2018 Congress in Munich underline the value of
Lung cancer, a multifaceted disease, demands tailored therapeutic approaches due to its diverse subtypes and stages. This comprehensive review explores the intricate landscape of lung cancer research, delving into recent breakthroughs and their implications for diagnosis, therapy, and prevention. Genomic pr...
First Time Ever, Cuban Lung Cancer Vaccine Being Tested In U.S. Trial A New York cancer research and treatment center has received approval from the Food and Drug Administration to conduct a clinical trial of an innovative lung cancer vaccine developed in Cuba. Oct 27, 2016 $16M Given ...
This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.Latest News REZILIENT1 Study of Zipalertinib in Pretreated EGFR-Mutant NSCLC Meets ORR Primary End Point By Kyle Doherty ...